Chong H. Chae
Daejeon, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
5-(Benzofuran-2-yl)-3-(2-chloro-4-fluorobenzyl)-1,3,4-oxadiazol-2(3H)-one (GM-90663) Alleviates Dravet Syndrome via Inhibiting Monoamine Oxidase Activity.
Journal: Molecules (Basel, Switzerland)
Published: March 30, 2026
Development of MKI-3: A Potent and Selective MASTL Inhibitor with Improved Efficacy for Cancer Treatment.
Journal: Journal of medicinal chemistry
Published: March 20, 2026
Inhibitors of acetohydroxyacid synthase as promising agents against non-tuberculous mycobacterial diseases.
Journal: The Journal of antibiotics
Published: April 26, 2024
Novel hematopoietic progenitor kinase 1 inhibitor KHK-6 enhances T-cell activation.
Journal: PloS one
Published: January 22, 2024
DW71177: A novel [1,2,4]triazolo[4,3-a]quinoxaline-based potent and BD1-Selective BET inhibitor for the treatment of acute myeloid leukemia.
Journal: European journal of medicinal chemistry
Published: October 10, 2023
Synthesis and evaluation of tirbanibulin derivatives: a detailed exploration of the structure-activity relationship for anticancer activity.
Journal: RSC advances
Published: October 06, 2023
Novel allosteric glutaminase 1 inhibitors with macrocyclic structure activity relationship analysis.
Novel allosteric glutaminase 1 inhibitors with macrocyclic structure activity relationship analysis.
Journal: Bioorganic & medicinal chemistry letters
Published: June 21, 2022
A novel IRAK4/PIM1 inhibitor ameliorates rheumatoid arthritis and lymphoid malignancy by blocking the TLR/MYD88-mediated NF-κB pathway.
Journal: Acta pharmaceutica Sinica. B
Published: June 07, 2022
Neurotoxicological Profiling of Paraquat in Zebrafish Model.
Journal: Neurochemical research
Published: January 14, 2022
Rotational Variance-Based Data Augmentation in 3D Graph Convolutional Network.
Journal: Chemistry, an Asian journal
Published: July 12, 2021
Discovery and Characterization of a Novel MASTL Inhibitor MKI-2 Targeting MASTL-PP2A in Breast Cancer Cells and Oocytes.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 14, 2021
Novel QSAR Models for Molecular Initiating Event Modeling in Two Intersecting Adverse Outcome Pathways Based Pulmonary Fibrosis Prediction for Biocidal Mixtures.
Journal: Toxics
Published: December 08, 2020
Last Updated: 09/26/2026